Recent advances in genetic polymorphism and gene editing technologies have opened up exciting opportunities for research and development. With the continued progress in these areas, we can look forward to a future where genetic diseases can be diagnosed and treated more effectively, ultimately improving the quality of life for millions of people worldwide. In this presentation, I will be focusing on the recent advances in genetic polymorphism and how gene editing and CRISPR technologies are shaping the future of genetic research. I will discuss the recent developments in understanding gene expression and the role it plays in genetic polymorphisms. Additionally, I will highlight the recent progress in gene editing technologies, including the development of new CRISPR systems and their applications in treating genetic diseases. Finally, I will discuss the future prospects of gene editing and CRISPR technologies, including the ethical considerations and the challenges that lie ahead.

Prof. Dr. A Taha is a Visiting Professor and External Advisor from New Zealand, and a High-end Foreign Expert at WUC Malaysia & CDU China. Research interests include biomedical engineering, genetic polymorphism effective delivery for genes in vitro, gene knock in and genomic screening, and various topics related to biomedical research. the research results have been published in more than 50 papers in international journals and conferences, including various sci/scie/ieee indexing. received various awards such as chosen for who’s who in medicine and Healthcare 2010. Currently an editorial board member for several international journals.

Prof. Dr. A Taha, MSc, PhD

Auckland, New Zealand |

MMC Reg. No. 74494

ORCID: https://orcid.org/0000-0003-3831-2459

Scopus Author ID: 57201420645

Web of Science ResearcherID: AAN-4913-2020; Google Scholar Prof Dr. Ahmad Taha Khalaf.